Steven Cohen's position in Ascendis Pharma A/S is currently worth $80.3 Million. That's 0.25% of their equity portfolio (116th largest holding). The first Ascendis Pharma A/S trade was made in Q1 2020. Since then Steven Cohen bought shares eight more times and sold shares on five occasions. The stake costed the investor $68 Million, netting the investor a gain of 18% so far.